NEU New patent issued to 2032 for Neuren's trofinetide in Canada 29/04/21 PRICE SENSITIVE download Created with Sketch. 155.06KB Share NEU Appendix 4G 27/04/21 download Created with Sketch. 174.72KB Share NEU Annual Report to shareholders 27/04/21 download Created with Sketch. 1.79MB Share NEU Quarterly report and cash flow statement for Q1 2021 22/04/21 PRICE SENSITIVE download Created with Sketch. 263.27KB Share NEU Investor presentation, 23 March 2021 23/03/21 download Created with Sketch. 852.54KB Share NEU S&P DJI Announces March 2021 Quarterly Rebalance 12/03/21 PRICE SENSITIVE download Created with Sketch. 183.24KB Share NEU Neuren successfully completes manufacturing for Phase 2 10/03/21 PRICE SENSITIVE download Created with Sketch. 183.13KB Share NEU Neuren corporate presentation, 24 February 2021 24/02/21 download Created with Sketch. 856.82KB Share NEU Neuren approaching transforming milestones in 2021 24/02/21 PRICE SENSITIVE download Created with Sketch. 163.7KB Share NEU Preliminary Final Report and 2020 full year accounts 24/02/21 PRICE SENSITIVE download Created with Sketch. 508.05KB Share NEU Change of Director's Interest Notice 18/02/21 download Created with Sketch. 96.2KB Share NEU Notification of investor briefing webinar 17/02/21 download Created with Sketch. 91.52KB Share NEU Neuren adds Prader-Willi syndrome to NNZ-2591 pipeline 16/02/21 PRICE SENSITIVE download Created with Sketch. 225KB Share NEU Successful Phase 1 trial for Neuren's NNZ-2591 15/02/21 PRICE SENSITIVE download Created with Sketch. 153.49KB Share NEU Quarterly report and cash flow statement for Q4 2020 29/01/21 PRICE SENSITIVE download Created with Sketch. 204.13KB Share NEU European Commission grants 3 NNZ-2591 Orphan designations 11/01/21 PRICE SENSITIVE download Created with Sketch. 143.44KB Share NEU Notification of investor briefing webinar 07/12/20 download Created with Sketch. 91.61KB Share NEU Positive opinion for all 3 Orphan applications in Europe 07/12/20 PRICE SENSITIVE download Created with Sketch. 145.2KB Share NEU Approval received for final stage of NNZ-2591 clinical trial 19/11/20 PRICE SENSITIVE download Created with Sketch. 129.76KB Share NEU Quarterly report and cash flow statement for Q3 2020 29/10/20 PRICE SENSITIVE download Created with Sketch. 265.24KB Share NEU Neuren requests Orphan designations for NNZ-2591 in Europe 29/09/20 download Created with Sketch. 143.42KB Share NEU Neuren initiates manufacture of NNZ-2591 for Phase 2 trials 22/09/20 PRICE SENSITIVE download Created with Sketch. 142.98KB Share NEU Half-year Shareholder Update 26/08/20 download Created with Sketch. 230.75KB Share NEU Half Yearly Report and Accounts 26/08/20 PRICE SENSITIVE download Created with Sketch. 274.21KB Share NEU Corporate presentation, 18 August 2020 18/08/20 download Created with Sketch. 835.84KB Share NEU Change of Director's Interest Notice 11/08/20 download Created with Sketch. 34.47KB Share NEU Appendix 2A 07/08/20 download Created with Sketch. 156.47KB Share NEU Change of Director's Interest Notice 07/08/20 download Created with Sketch. 34.67KB Share NEU Completion of Share Purchase Plan 05/08/20 download Created with Sketch. 119.02KB Share NEU Appointment of CFO & Company Secretary 30/07/20 download Created with Sketch. 117.52KB Share NEU Q2 2020 Activity Report and Cash Flow Report 27/07/20 PRICE SENSITIVE download Created with Sketch. 193.97KB Share NEU Final share buy-back notice - Appendix 3F 14/07/20 download Created with Sketch. 62.78KB Share NEU Announcement of buy-back - Appendix 3C 14/07/20 download Created with Sketch. 75.11KB Share NEU Publications and presentations for trofinetide and NNZ-2591 14/07/20 download Created with Sketch. 124.83KB Share NEU Appendix 3G 13/07/20 download Created with Sketch. 127.77KB Share NEU Share Purchase Plan Offer Booklet 09/07/20 download Created with Sketch. 202.53KB Share NEU Section 708A notice 06/07/20 download Created with Sketch. 162.42KB Share NEU Appendix 2A 06/07/20 download Created with Sketch. 162.03KB Share NEU Electing to receive SPP documents by e-mail 01/07/20 download Created with Sketch. 124.03KB Share NEU Results of Meeting 29/06/20 download Created with Sketch. 62.65KB Share NEU AGM Chairman's Address and CEO Presentation 29/06/20 download Created with Sketch. 550.99KB Share NEU Proposed issue of Securities - NEU 29/06/20 PRICE SENSITIVE download Created with Sketch. 33.15KB Share NEU Neuren successfully completes $20m capital raising 29/06/20 PRICE SENSITIVE download Created with Sketch. 131.12KB Share NEU Trading Halt 25/06/20 PRICE SENSITIVE download Created with Sketch. 160.11KB Share NEU Temporary enrolment pause ended in Phase 3 trial in the US 16/06/20 PRICE SENSITIVE download Created with Sketch. 242.24KB Share NEU Change of Director's Interest Notice 02/06/20 download Created with Sketch. 34.27KB Share NEU Change of Director's Interest Notice 01/06/20 download Created with Sketch. 34.41KB Share NEU Final Director's Interest Notice 29/05/20 download Created with Sketch. 26.33KB Share NEU Virtual AGM online guide 28/05/20 download Created with Sketch. 1.14MB Share NEU Notice of Annual General Meeting/Proxy Form 28/05/20 download Created with Sketch. 247.4KB Share NEU Neuren announces changes to leadership team 27/05/20 PRICE SENSITIVE download Created with Sketch. 132.46KB Share NEU Neuren commences first clinical trial for NNZ-2591 07/05/20 PRICE SENSITIVE download Created with Sketch. 121.9KB Share NEU Appendix 4G 29/04/20 download Created with Sketch. 109.71KB Share NEU Annual Report 2019 29/04/20 download Created with Sketch. 1.58MB Share NEU Appendix 4C - quarterly 17/04/20 PRICE SENSITIVE download Created with Sketch. 55.99KB Share NEU Q1 2020 Activity Report 17/04/20 PRICE SENSITIVE download Created with Sketch. 131.81KB Share NEU Corporate presentation, 6 April 2020 06/04/20 download Created with Sketch. 1.14MB Share NEU First patent in Israel granted for trofinetide 02/04/20 PRICE SENSITIVE download Created with Sketch. 118.28KB Share NEU Change of Director's Interest Notice 26/03/20 download Created with Sketch. 34.3KB Share NEU International institution acquires 14% of Neuren 26/03/20 download Created with Sketch. 119.14KB Share NEU Change of Director's Interest Notice 24/03/20 download Created with Sketch. 34.31KB Share NEU Temporary pause in new enrolments for LAVENDER trial in US 24/03/20 PRICE SENSITIVE download Created with Sketch. 198.24KB Share NEU Trading Halt 20/03/20 PRICE SENSITIVE download Created with Sketch. 145.49KB Share NEU Neuren to capture substantially greater value after Phase 3 17/03/20 PRICE SENSITIVE download Created with Sketch. 138.58KB Share NEU Additional information 10/03/20 download Created with Sketch. 97.07KB Share NEU Compelling results for 2591 dose ranging study in PMS model 06/03/20 PRICE SENSITIVE download Created with Sketch. 184.18KB Share NEU Commentary on potential benefit to Neuren of RPD designation 04/03/20 PRICE SENSITIVE download Created with Sketch. 154.06KB Share NEU Rare Pediatric Disease designation received from FDA 04/03/20 PRICE SENSITIVE download Created with Sketch. 182.01KB Share NEU 5 Orphan Drug programs and Rett in Phase 3 funded by partner 26/02/20 download Created with Sketch. 814.8KB Share NEU Appendix 4E and 2019 full year accounts 26/02/20 PRICE SENSITIVE download Created with Sketch. 1.15MB Share NEU Update on trofinetide Phase 3 trial in Rett syndrome 19/02/20 PRICE SENSITIVE download Created with Sketch. 101.14KB Share NEU Appendix 4C - quarterly 28/01/20 PRICE SENSITIVE download Created with Sketch. 47.49KB Share NEU 2019 year-end update and 2020 outlook 12/12/19 PRICE SENSITIVE download Created with Sketch. 125.65KB Share NEU Patent to 2034 granted in Europe for Neuren's NNZ-2591 03/12/19 PRICE SENSITIVE download Created with Sketch. 122.35KB Share NEU Phase 3 trial of trofinetide in Rett syndrome commences 31/10/19 PRICE SENSITIVE download Created with Sketch. 332.86KB Share NEU Neuren Corporate Presentation, October 2019 18/10/19 download Created with Sketch. 1.04MB Share NEU Appendix 4C - quarterly 17/10/19 PRICE SENSITIVE download Created with Sketch. 47.73KB Share NEU FDA grants Orphan for both Phelan-McDermid and Pitt Hopkins 16/10/19 PRICE SENSITIVE download Created with Sketch. 121.85KB Share NEU Pause in Trading 16/10/19 PRICE SENSITIVE download Created with Sketch. 117.01KB Share NEU FDA grants Orphan Drug Designation for NNZ-2591 in Angelman 11/10/19 PRICE SENSITIVE download Created with Sketch. 120.99KB Share NEU Neuren approaching key milestones in Q4 2019 20/09/19 PRICE SENSITIVE download Created with Sketch. 122.21KB Share NEU Neuren advances pipeline for neurodevelopmental disorders 28/08/19 download Created with Sketch. 165.32KB Share NEU Half Yearly Report and Accounts 28/08/19 PRICE SENSITIVE download Created with Sketch. 1.37MB Share NEU New patent granted for Neuren's NNZ-2591 in Japan 16/08/19 download Created with Sketch. 121.12KB Share NEU Appendix 4C - quarterly 31/07/19 PRICE SENSITIVE download Created with Sketch. 140.75KB Share NEU Neuren submits 3 NNZ-2591 Orphan Drug applications to FDA 29/07/19 download Created with Sketch. 122.4KB Share NEU Neuren receives final payment from Lanstead Capital 16/07/19 download Created with Sketch. 117.91KB Share NEU Results of Meeting 28/05/19 download Created with Sketch. 57.97KB Share NEU Chairman's Address at 2019 Annual Meeting of Shareholders 28/05/19 download Created with Sketch. 141.74KB Share NEU Validation for NNZ-2591 neurodevelopmental disorder pipeline 17/05/19 download Created with Sketch. 123.84KB Share NEU NNZ-2591 positive effects in Pitt Hopkins syndrome model 17/05/19 PRICE SENSITIVE download Created with Sketch. 121.68KB Share NEU NNZ-2591 positive effects in Angelman syndrome model 17/05/19 PRICE SENSITIVE download Created with Sketch. 121.73KB Share NEU Appendix 4C - quarterly 30/04/19 PRICE SENSITIVE download Created with Sketch. 48.3KB Share NEU Notice of Annual General Meeting/Proxy Form 29/04/19 download Created with Sketch. 207.53KB Share NEU Appendix 4G 26/04/19 download Created with Sketch. 121.86KB Share NEU Annual Report to shareholders 26/04/19 download Created with Sketch. 1.35MB Share NEU Update on development plan for NNZ-2591 26/04/19 PRICE SENSITIVE download Created with Sketch. 131.77KB Share NEU Neuren's Rett syndrome Phase 2 trial published in Neurology 28/03/19 PRICE SENSITIVE download Created with Sketch. 239.68KB Share NEU Fundamentals strong as Neuren advances neuroscience pipeline 27/02/19 download Created with Sketch. 125.29KB Share NEU Preliminary Final Report and statutory accounts 27/02/19 PRICE SENSITIVE download Created with Sketch. 458.14KB Share
(20min delay)
